Skip to content
★ Sign in to follow
JM

Joseph M. Lobacki

Executive
Medivation, Inc.Verastem, Inc.
Total declarations
4
Companies
2
▲ Purchases (2 ops.)
€57k
▼ Sales (1 ops.)
€131k

Latest filing published 02 Oct 2018 for Verastem, Inc., €19k.

Filing timeline

BuySale
Joseph M. Lobacki

Insider track record

Disclosed buys
2
Disclosed sells
1
Signal history

Closed purchases

Market purchases
2
Positive at T+90
50%
Median T+90
+6.8%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 02 Oct 2018 · 2960 days ago · €19k
    -82.6%
    Entry US$84.12 · Close at T+365 US$14.64
  • Filed 12 Jun 2018 · 3072 days ago · €38k
    -77.6%
    Entry US$67.92 · Close at T+365 US$15.24

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Joseph M. Lobacki: trading record in brief

This profile gathers the share dealings of Joseph M. Lobacki across 2 companies, led by Medivation, Inc. and Verastem, Inc. Between 12 December 2014 and 28 September 2018, the trades on record add up to 4 filings.

Both buying and selling appear: 2 purchases worth €57k, against 1 sale worth €131k. Netting one side against the other leaves €75k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant. In 2018 alone, the filings show 2 purchases and no sales.

The latest filing, published on 2 October 2018, reports an open-market purchase of €19k in Verastem, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Joseph M. Lobacki

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▲
    Executive VP & CCOExecutivesVerastem, Inc.
    21,900 USD34SEC
    3,000 shares@ US$7.3033.2% of flowCommon StockSEC:0000904454-18-000633:0
    Canonical exit: 27 Dec 2018 (T+90)
  • ▲
    Executive VP & CCOExecutivesVerastem, Inc.
    44,583 USD30SEC
    7,700 shares@ US$5.7966.8% of flowCommon StockSEC:0001104659-18-039657:0
    Canonical exit: 6 Sept 2018 (T+90)
  • ▼
    Chief Commercial OfficerExecutivesMedivation, Inc.
    142,523 USD19SEC
    3,065 shares@ US$46.50100.0% of flowCommon StockSEC:0001209191-16-089278:0
  • ◆
    Chief Commercial OfficerExecutivesMedivation, Inc.
    0SEC
    11,215 shares0Common StockSEC:0001209191-14-075504:0

4 of 4 declarations